These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 11820950)
1. [The effect of inhaled ipratropium bromide on airway and lung tissue muscarinic receptors in a rat model of COPD]. Yao W; Wang G; Zhu H; Zhao M Zhonghua Jie He He Hu Xi Za Zhi; 1999 Feb; 22(2):95-7. PubMed ID: 11820950 [TBL] [Abstract][Full Text] [Related]
2. Effect of ipratropium bromide on airway and pulmonary muscarinic receptors in a rat model of chronic obstructive pulmonary disease. Yao W; Wang G; Zhu H; Sun Y; Zhao M Chin Med J (Engl); 2001 Jan; 114(1):80-3. PubMed ID: 11779443 [TBL] [Abstract][Full Text] [Related]
3. [Effects of salbutamol and ipratropium bromide on arterial blood gases in patients with stable COPD]. Ozdemir T; Geçkin E; Oğüş C; Cilli A Tuberk Toraks; 2003; 51(2):132-7. PubMed ID: 15143418 [TBL] [Abstract][Full Text] [Related]
4. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors]. Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836 [TBL] [Abstract][Full Text] [Related]
6. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. Balkissoon R; Make B COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147 [TBL] [Abstract][Full Text] [Related]
7. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD. O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054 [TBL] [Abstract][Full Text] [Related]
9. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD. Brophy C; Kastelik J; Gardiner E; Greenstone M Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097 [TBL] [Abstract][Full Text] [Related]
10. Function of pulmonary neuronal M(2) muscarinic receptors in stable chronic obstructive pulmonary disease. On LS; Boonyongsunchai P; Webb S; Davies L; Calverley PM; Costello RW Am J Respir Crit Care Med; 2001 May; 163(6):1320-5. PubMed ID: 11371395 [TBL] [Abstract][Full Text] [Related]
11. [Tiotropium (Spiriva) - a long-acting inhaled anticholinergic for the treatment of chronic obstructive pulmonary disease (COPD)]. Beeh KM; Welte T; Buhl R Pneumologie; 2003 Sep; 57(9):519-25. PubMed ID: 13680472 [TBL] [Abstract][Full Text] [Related]
12. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011 [TBL] [Abstract][Full Text] [Related]
13. [Tiotropium as a controller of bronchoconstriction]. Lubiński W Pol Merkur Lekarski; 2004 May; 16 Suppl 1():75-6, 78. PubMed ID: 15524023 [TBL] [Abstract][Full Text] [Related]
15. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen. Rascati KL; Akazawa M; Johnsrud M; Stanford RH; Blanchette CM Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734 [TBL] [Abstract][Full Text] [Related]
16. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease. Koumis T; Samuel S Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812 [TBL] [Abstract][Full Text] [Related]
17. A pilot study comparing the antispasmodic effects of inhaled salmeterol, salbutamol and ipratropium bromide using different aerosol devices on muscarinic bronchoconstriction in healthy cats. Leemans J; Kirschvink N; Bernaerts F; Clercx C; Cambier C; Gustin P Vet J; 2009 May; 180(2):236-45. PubMed ID: 18294877 [TBL] [Abstract][Full Text] [Related]
18. Comparative characterization of lung muscarinic receptor binding after intratracheal administration of tiotropium, ipratropium, and glycopyrrolate. Ogoda M; Niiya R; Koshika T; Yamada S J Pharmacol Sci; 2011; 115(3):374-82. PubMed ID: 21358117 [TBL] [Abstract][Full Text] [Related]
19. [What dosage is sufficient in combined inhalation therapy (fenoterol + ipratropium bromide) in patients with exacerbation of chronic obstructive lung disease?]. Musil J; Hirsch V; Vondra V; Reisová M Vnitr Lek; 1998 Jul; 44(7):415-7. PubMed ID: 9748878 [TBL] [Abstract][Full Text] [Related]
20. Mineral status of COPD patients under long-term inhaled corticosteroid therapy. Buyukkaplan US; Akkaya A; Yildiz M; Bircan A; Aksoy Dogan A; Ozturk O J Prosthodont; 2008 Aug; 17(6):462-7. PubMed ID: 18573148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]